| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Section on Endocrine Physiology, Developmental Endocrinology Branch, National Institute of Child Health and Human Development and
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1862, USA; and
Department of Internal Medicine, University of Leipzig, Germany
1Correspondence: Developmental Endocrinology Branch, NICHD, NIH, Bldg. 10, Rm. 10n262, 10 Center Drive MSC 1862, Bethesda, Maryland 20892-1862, USA. E-mail: Bornstes{at}mail.nih.gov
Deficiency of 21-hydroxylase (21-OH), one of the most common genetic defects in humans, causes low glucocorticoid and mineralocorticoid production by the adrenal cortex, but the effect of this disorder on the adrenomedullary system is unknown. Therefore, we analyzed the development, structure, and function of the adrenal medulla in 21-OH-deficient mice, an animal model resembling human congenital adrenal hyperplasia. Chromaffin cells of 21-OH-deficient mice exhibited ultrastructural features of neuronal transdifferentiation with reduced granules, increased rough endoplasmic reticulum and small neurite outgrowth. Migration of chromaffin cells in the adrenal to form a central medulla was impaired. Expression of phenylethanolamine-N-methyltransferase (PNMT) was reduced to 27 ± 9% (P<0.05), as determined by quantitative TaqMan polymerase chain reaction, and there was a significant reduction of cells staining positive for PNMT in the adrenal medulla of the 21-OH-deficient mice. Adrenal contents of epinephrine were decreased to 30 ± 2% (P<0.01) whereas norepinephrine and dopamine levels were reduced to 57 ± 4% (P<0.01) and 50 ± 9% (P<0.05), respectively. 21-OH-deficient mice demonstrate severe adrenomedullary dysfunction, with alterations in chromaffin cell migration, development, structure, and catecholamine synthesis. This hitherto unrecognized mechanism may contribute to the frequent clinical, mental, and therapeutic problems encountered in humans with this genetic disease.—Bornstein, S. R., Tajima, T., Eisenhofer, G., Haidan, A., Aguilera, G. Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice.
Key Words: 21-OH deficiency • adrenal medulla • catecholamine synthesis
This article has been cited by other articles:
|
|
 |
|
  C. G. Ziegler, F. Sicard, P. Lattke, S. R. Bornstein, M. Ehrhart-Bornstein, and A. W. Krug Dehydroepiandrosterone Induces a Neuroendocrine Phenotype in Nerve Growth Factor-Stimulated Chromaffin Pheochromocytoma PC12 Cells Endocrinology, January 1, 2008; 149(1): 320 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Hebert and M. Molinari In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases Physiol Rev, October 1, 2007; 87(4): 1377 - 1408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Riepe, S. Tatzel, W. G. Sippell, J. Pleiss, and N. Krone Congenital Adrenal Hyperplasia: The Molecular Basis of 21-Hydroxylase Deficiency in H-2aw18 Mice Endocrinology, June 1, 2005; 146(6): 2563 - 2574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Coutant, H. Maurey, S. Rouleau, E. Mathieu, P. Mercier, J. M. Limal, and A. Le Bouil Defect in Epinephrine Production in Children with Craniopharyngioma: Functional or Organic Origin? J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5969 - 5975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Charmandari, G. Eisenhofer, S. L. Mehlinger, A. Carlson, R. Wesley, M. F. Keil, G. P. Chrousos, M. I. New, and D. P. Merke Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3031 - 3037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Merke, S. R. Bornstein, N. A. Avila, and G. P. Chrousos Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Ann Intern Med, February 19, 2002; 136(4): 320 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zuckerman-Levin, D. Tiosano, G. Eisenhofer, S. Bornstein, and Z.'e. Hochberg The Importance of Adrenocortical Glucocorticoids for Adrenomedullary and Physiological Response to Stress: A Study in Isolated Glucocorticoid Deficiency J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5920 - 5924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Bornstein, H. Tian, A. Haidan, A. Bottner, N. Hiroi, G. Eisenhofer, S. M. McCann, G. P. Chrousos, and S. Roffler-Tarlov Deletion of tyrosine hydroxylase gene reveals functional interdependence of adrenocortical and chromaffin cell system in vivo PNAS, December 19, 2000; 97(26): 14742 - 14747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Merke, G. P. Chrousos, G. Eisenhofer, M. Weise, M. F. Keil, A. D. Rogol, J. J. V. Wyk, and S. R. Bornstein Adrenomedullary Dysplasia and Hypofunction in Patients with Classic 21-Hydroxylase Deficiency N. Engl. J. Med., November 9, 2000; 343(19): 1362 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. White and P. W. Speiser Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Endocr. Rev., June 1, 2000; 21(3): 245 - 291. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
